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Fig. 1 Apoptotic caspases in mammals. Effector caspases, caspase 3-6-7,
consist of small and large subunit, which are separated when activated
through cleavage by initiator caspases. Initiator caspases, caspase 2-8-9-10,
posses an extended N-terminal region, which contains a caspase recruitment
domain (CARD) or death effector domain (DED). They are important for
protein-protein interaction and auto-activation of initiator caspases.





















Fig. 2 Simplified representation of the intrinsic and extrinsic apoptotic
pathway. Activation of caspase 9 after cytochrome c release from
mitochondria leads to activation of caspase 3 during the intrinsic apoptotic
pathway. Members of the BCl-2 protein family play a regulatory role during
this process. Activation of caspase 8 after binding of a death ligand to its
receptor and subsequent activation of caspase 3 results in cell death during
the extrinsic apoptotic pathway.





















































Fig. 3 Members of the core BCl-2 protein family and BH3-only proteins. They can be divided
into antiapoptotic and proapoptotic proteins. Structural motifs, BH1-4, are shown. Members of
antiapoptotic BCl-2 proteins posses BH1-4 motifs, whereas proapoptotic proteins have BH1-3.
BH3-only proteins are key regulators of core BCl-2 proteins.



















Fig. 4 Scheme depicting intrinsic and extrinsic pathways of apoptosis.
BH3-only proteins may act proapoptotic by inhibiting antiapoptotic BCl-2
proteins or by direct activation of BAX/BAK. The extrinsic pathway may
intersect with the intrinsic pathway through BID, a member of BH3-only
proteins.





























































Fig. 5 Formation, effects and inactivation of reactive oxygen species in
mitochondria. GSH reduced glutathione, GSSG glutathione disulfide,
Gpx glutathione peroxidase, Grx glutaredoxin, IDHm mitochondrial
isocitrate dehydrogenase, NADP nicotinamide adenine dinucleotide
phosphate, Prx peroxiredoxin, SOD superoxide dismutase, TH
transhydrogenase, Trx thioredoxin, TrxR thioredoxin reductase.

























Fig. 6 Ubiquitin and the marking of proteins with polyubiquitin chains. The process of
polyubiquitinylation marks proteins for degradation by the proteasome.
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Fig. 7 Chemical structure of Hinokitiol (1),
























































































































































































































































































































































































Separating gel  7,5%  10%  12,5%    Stacking gel   
             
30% Acrylamide  1,5 ml  2 ml  2,5 ml    Stack solution  2 ml 
4 x LGS  1,5 ml  1,5 ml  1,5 ml    10% APS  12 µl 
H2O  3 ml  2,5 ml  2 ml    TEMED  4 µl 
10% APS  36 µl  36 µl  36 µl       























































































M    DOX   PDTC P+D     M  DOX PDTC P+D HRV14







Fig. 9 PDTC does not inhibit eIF4GI cleavage by HRV2 2A protease.
Protein expression in HeLa 2Apro and HeLa 2Aproi cells was induced by
addition of 1µg/ml doxycyclin (DOX). In addition, cells were treated with
125 µM PDTC (PDTC) or 125 µM PDTC and 1 µg/ml doxycycline (P+D).
HeLa cells infected with HRV14 were used as positive control. M
represents untreated cells. Protein extracts were prepared after 20 h and


































































M       P     A   P      A       
+ PDTC  














M        T        F       T       F  
+ PDTC 
PDTC
Fig. 10 PDTC acts antiapoptotic in HeLa cells. Apoptosis was
induced with 50 µM Puromycin (P), 1 µM Actinomycin D (A),
50 ng/ml TNF α and 10 µM CHX (T) or 0,3 µg/ml FasL
antibody and 10 µM CHX (F). In addition, cells were treated
with 125 µM PDTC. M represents untreated HeLa cells.
Protein extracts were prepared after 8 h and Western Blot








































Fig. 11 PDTC inhibits the
proteasome dependent
proteolysis in HeLa cells.
HeLa cells were treated
with 1 µM MG132 or 125
µM PDTC for 8 h. M re-
presents untreated cells.






































Fig. 12 The antiapoptotic effect of PDTC is not linked to
proteasome inhibition. Apoptosis was induced with 50 µM
Puromycin (P), 1 µM Actinomycin D (A) or 50 ng/ml TNF α and
10 µM CHX (T). In addition, cells were treated with 125 µM
PDTC or 1 µM MG132. M represents untreated cells. Protein


















Actinomycin D  6h                     Puromycin  4h                        TNF α, CHX  4h 
red: mock       green: H2O2 orange: apoptosis inducer blue: apoptosis inducer + PDTC 
Fig. 13 Oxidative stress is not linked to the antiapoptotic effect of PDTC. HeLa cells were treated
with 1 µM Actinomycin D, 50 µM Puromycin or 50 ng/ml TNF α and 10 µM CHX for the indicated
time points as apoptosis inducers. In addition, cells were treated with 125 µM PDTC. As positive
control cells treated with 5 mM H2O2 for 2 h were used. ROI detection by FACS was performed.







M    NAC   PDTC            P        A       T 
+ NAC
Fig. 14 The antiapoptotic effect of PDTC is not linked to
oxidative stress. Apoptosis was induced with 50 µM Puromycin
(P), 1 µM Actinomycin D (A) or 50 ng/ml TNF α and 10 µM
CHX (T). In addition, cells were treated with 125 µM PDTC or
10 mM NAC. M represents untreated cells. Protein extracts






























































M       P     A   P      A       P       A    P   A
+ PDTC  + PT          +HK














M        T        F       T       F       T      F        T        F
+ PDTC  + PT         +HK
PDTC   PT     HK
Fig. 15 PDTC, Pyrithione and Hinokitiol/MgCl2 act similar in HeLa cells. Apoptosis was induced with
50 µM Puromycin (P), 1 µM Actinomycin D (A), 50 ng/ml TNF α and 10 µM CHX (T) or 0,3 µg/ml
FasL antibody and 10 µM CHX (F). In addition, cells were treated with 125 µM PDTC, 12,5 µM
Pyrithione (PT) or 125 µM Hinokitiol and 30 mM MgCl2 (HK). M represents untreated cells. Protein
extracts were prepared after 8 h and Western Blot analysis for caspase 8, caspase 9, PARP and


























mock Puromycin 8h                      Puromycin 10h
PDTC                      Puromycin 8h + PDTC        Puromycin 10h + PDTC
BAX
mock Puromycin 8h                       Puromycin 10h
PDTC                    Puromycin 8h + PDTC        Puromycin 10h + PDTC
BAK
Fig. 16 PDTC is an inhibitor of the conformational change of BAX and BAK during
apoptosis. Apoptosis in HeLa cells was induced with 50 µM Puromycin for indicated
time points. In addition, cells were treated with 125 µM PDTC. Mock represent untreated
cells. FACS analysis was performed using BAX and BAK antibodies, which specifically



























mock 6h 8h 10h
%
Conformational change of BAX
1 µM Actinomycin
1 µM Actinomycin + 125 µM PDTC
50 µM Puromycin










mock 6h 8h 10h
%
Conformational change of BAK
1 µM Actinomycin
1 µM Actinomycin + 125 µM PDTC
50 µM Puromycin
50 µM Puromycin + 125 µM PDTC
Fig. 17 Conformational change of BAX/BAK shown in percentage based
on gate settings. Apoptosis was induced with 50 µM Puromycin or 1µM
Actinomycin D. In addition, cells were treated with 125 µM PDTC. Mock






















Conformational change of BAX/BAK
50 ng/ml TNFα, 10 µM CHX - BAX
50 ng/ml TNFα, 10 µM CHX + 125 µM PDTC - BAX
50 ng/ml TNFα, 10 µM CHX - BAK
50 ng/ml TNFα, 10 µM CHX + 125 µM PDTC - BAK
Fig. 18 Conformational change of BAX/BAK shown in percentage based
on gate settings. Apoptosis was induced with 50 ng/ml TNF α and 10 µM
CHX. In addition, cells were treated with 125 µM PDTC. Mock represent













Conformational change of BAX
0,3 µg/ml FasL, 10 µM CHX 0,3 µg/ml FasL, 10 µM CHX + 125 µM PDTC
Fig. 19 Conformational change of BAX shown in percentage based on
gate settings. Apoptosis was induced with 0,3 µg/ml FasL antibody and
10 µM CHX. In addition, cells were treated with 125 µM PDTC. Mock





















Fig. 20 Conformational change of BAX is shown in percentage based on gate settings.
Apoptosis was induced with 50 µM Puromycin for 8 h. In addition, cells were treated with






















































































































































































































































































































































































mock FasL, CHX 8h                     FasL, CHX 10h
PDTC                        FasL, CHX 8h + PDTC       FasL, CHX 10h + PDTC
BAX
Appendix 3 PDTC is an inhibitor of the conformational change of BAX during apoptosis.
Apoptosis in HeLa cells was induced with 0,3 µg/ml FasL antibody and 10 µM CHX for
indicated time points. In addition, cells were treated with 125 µM PDTC. Mock represent
untreated cells. FACS analysis was performed using BAX antibody.
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mock                            Actinomycin D 8h               Actinomycin D 10h
PDTC                  Actinomycin D 8h + PDTC Actinomycin D 10h + PDTC
BAX
mock                          Actinomycin D 8h               Actinomycin D 10h
PDTC                Actinomycin D 8h + PDTC Actinomycin D 10h + PDTC
BAK
Appendix 1 PDTC is an inhibitor of the conformational change of BAX and BAK during
apoptosis. Apoptosis in HeLa cells was induced with 1 µM Actinomycin D for indicated
time points. In addition, cells were treated with 125 µM PDTC. Mock represent




mock                              TNF α, CHX 4h                   TNF α, CHX 6h
PDTC                      TNF α, CHX 4h + PDTC       TNF α, CHX 6h + PDTC
BAX
mock                           TNF α, CHX 4h                     TNF α, CHX 6h
PDTC                    TNF α, CHX 4h + PDTC       TNF α, CHX 6h + PDTC
BAK
Appendix 2 PDTC is an inhibitor of the conformational change of BAX and BAK during
apoptosis. Apoptosis in HeLa cells was induced with 50 ng/ml TNF α and 10 µM CHX
for indicated time points. In addition, cells were treated with 125 µM PDTC. Mock













mock                                   PDTC 8h                           Pyrithione 8h
Puromycin 8h            Puromycin 8h + PDTC Puromycin 8h + Pyrithione
BAX
Appendix 4 Pyrithione and PDTC act similar. Apoptosis in HeLa cells was induced
with 50 µM Puromycin for indicated time points. In addition, cells were treated with 125
µM PDTC or 12,5 µM Pyrithione. Mock represent untreated cells. FACS analysis was
performed using BAX antibody.
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